A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapy

A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapy

Abstract Predictive markers and prognostic models are useful for the individualization of cancer treatment. In this study, we sought to identify clinical and molecular factors to predict overall survival in recurrent glioma patients receiving bevacizumab-containing regimens. A cohort of 102 patients...

Full description

Bibliographic Details
Main Authors: Shanmu Jin, Wenlin Chen, Xiaopeng Guo, Hao Xing, Huiyu Yang, Qianshu Liu, Delin Liu, Kun Zhang, Hai Wang, Yu Xia, Siying Guo, Yaning Wang, Yixin Shi, Yilin Li, Yuekun Wang, Junlin Li, Jiaming Wu, Tingyu Liang, Tian Qu, Huanzhang Li, Tianrui Yang, Yu Wang, Wenbin Ma
Format: Article
Language:English
Published: Springer 2024-03-01
Series:Discover Oncology
Subjects:
Prognostic model
Prediction model
Overall survival
Recurrent glioma
Bevacizumab
WHO classification of CNS tumors
Online Access:https://doi.org/10.1007/s12672-024-00944-y

Internet

https://doi.org/10.1007/s12672-024-00944-y

Similar Items